Lung tumors shift identity making treatment more difficult
A new study co-led by the Institute for Systems Biology (ISB) shows that some lung cancers can change…
Nanomedicine offers targeted solutions for breast cancer treatment
Breast cancer (BCA) is one of the most common cancers worldwide, with high mortality and morbidity in women.…
Targeted diet helps reprogram aggressive neuroblastoma in mice
A new commentary spotlights preclinical evidence that blocking key amino acids, along with a polyamine-blocking drug, may force…
New blood test spots four cancers and other diseases by stripping away healthy DNA noise
By cutting through the overwhelming background of healthy blood DNA, MethylScan gives clinicians a clearer view of cancer,…
New blood biomarker improves cancer risk detection in people with Lynch Syndrome
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can…
Mayo Clinic researchers develop experimental nanotherapy to treat aggressive brain tumors
Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, according to…
JMIR Publications’ new article showcases the transformative potential of precision oncology
JMIR Publications today announced the release of a timely new article in its News and Perspectives section, showcasing…
Metformin mimics exercise-related metabolic effects in prostate cancer patients
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise’s core…
Metabolic pathways drive progression from pancreatic lesions to cancer
Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and has a low five-year survival rate.…
Tumor microenvironment drives resistance to ferroptosis in pancreatic cancer
Tumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can…
Study explores racial differences in gastric cancer immunotherapy outcomes
Advanced gastric cancer remains one of the deadliest malignancies, with a 5-year overall survival rate below 10%. In…
Study reveals how inflammation disrupts lymph node structure in lymphoma
In aggressive lymphomas, inflammatory messengers reprogram the “conductors” of the immune system, causing lymph nodes structure to collapse.…